Login / Signup

FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology.

Elizabeth S RussellElodie AubrunDaniela C MogaSandra GuedesWendy Camelo CastilloJanet R HardyJ Alexander ColeOladayo Jagun
Published in: Journal of clinical and translational science (2023)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial